← brief for 2026-10-13 · Slowing decline

Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications

Article No results yet Peer reviewed

Key takeaways

This review looks at how a nutrient called glutamine changes in people with kidney disease. It is a summary of past research, not a new trial. It aims to find new ways to treat kidney problems in the future.

Who did this work

RuoTong Xu (National Clinical Research) · Jin Zhao (National Clinical Research) · Minna Liu · Yifan Qiao (National Clinical Research) · Xiaoxuan Ning (Xijing Hospital) · Shiren Sun (National Clinical Research)

Source

Article · OpenAlex, CKD works · 2026-10-12
https://doi.org/10.3389/fimmu.2026.1939528